The role of adipose tissue in the pathogenesis of Crohn’s disease
- 1 February 2019
- journal article
- review article
- Published by Springer Nature in Pharmacological Reports
- Vol. 71 (1) , 105-111
Abstract
Crohn's disease (CD) is a chronic, immune system-mediated inflammatory disease affecting gastrointestinal (GI) tract. The pathogenesis of the intestinal lesions is not entirely explained and understood: excessive activation of the immune system may come as a result of the interaction of environmental, genetic and infectious factors and the mediation of abnormal intestinal flora. The main objective of the current study is to further identify the role of adipose tissue in the pathogenesis of CD. Alterations in body fat distribution, accumulation of intra-abdominal white adipose tissue (WAT) and mesenteric obesity are well-known features of CD. Up to date, data concerning the role of WAT in the pathogenesis of CD is limited with only a few studies on the relationship between WAT and the course of the disease, as well as pro- and anti-inflammatory cytokine profile and general immune system functioning. In this review, we focus on the importance of physiological and pathophysiological WAT functions and secreted adipokines, which seem to have a vital role in the inflammatory and fibrotic processes in CD sufferers.Keywords
Funding Information
- Medical University of Lodz (564/5-000-00/564-20-015)
- National Science Center (UMO-2016/23/N/NZ5/02564)
This publication has 56 references indexed in Scilit:
- Impact of environmental and dietary factors on the course of inflammatory bowel diseaseWorld Journal of Gastroenterology, 2012
- Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?Gut, 2011
- The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseasesClinical and Experimental Immunology, 2011
- Leptin, from fat to inflammation: old questions and new insightsFEBS Letters, 2004
- Adiponectin, obesity, and cardiovascular diseaseBiochimie, 2004
- Resistin is expressed in human macrophages and directly regulated by PPARγ activatorsBiochemical and Biophysical Research Communications, 2003
- Leptin: a review of its peripheral actions and interactionsInternational Journal of Obesity, 2002
- Secretion of Adiponectin and Regulation of apM1 Gene Expression in Human Visceral Adipose TissueBiochemical and Biophysical Research Communications, 2001
- Activation of nuclear factor κB in inflammatory bowel diseaseGut, 1998
- cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)Biochemical and Biophysical Research Communications, 1996